by David Brindley | Dec 18, 2012
Some words have the ability to induce instant and unexplained anxiety. In developing industries, such as cell therapy, one such example is regulation – of any sort. Crudely, our negative perception of regulation can be attributed to two factors: an aversion to both...
by David Brindley | Nov 30, 2012
The global health care sector is innovative, impactful and, despite addressing fundamental problems in human health, can be inescapably faddish. Despite the industry’s pride in an empirical approach that yields robust and practicable data, the covers of Nature,...
by David Brindley | Nov 5, 2012
Recently, in the twilight on a balmy summer’s evening in DC, an irrationally passionate cell therapy war room convened over meze, ouzo and retsina. And considered the meaty question posed by Lonza’s Jon Rowley: “Where do you think you and the cell therapy industry...
by Michelle Ly | Jul 4, 2012
With rain, rain and more rain in the forecast, I was more than happy to escape wet and dreary Vancouver and attend the 18th International Society for Cellular Therapy (ISCT) annual meeting, which took place in Seattle, Washington last month. The weather was (slightly)...
Comments